In a recent work conducted by Bao et al. [18], it was shown that CD133+ glioma stem cells contributed to glioma radioresistance via the preferential activation of DNA damage checkpoint response and an increase in DNA repair capacity as compared to CD133- tumor cells. The gene discussed is PROM1; the disease is central nervous system cancer.